NCT03047005View on ClinicalTrials.gov

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

December 16, 2021

Study Completion Date

December 16, 2022

Conditions
Binge-Eating DisorderObesity
Interventions
DRUG

NB medication (Naltrexone Bupropion combination)

NB medication

OTHER

Placebo

Placebo

Trial Locations (1)

06520

Yale School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER

NCT03047005 - Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy | Biotech Hunter | Biotech Hunter